Suppr超能文献

以模型药物作为成孔剂实现无水溶性琥珀酸美托洛尔从乙基纤维素包衣微丸的控释且无滞后阶段:机遇与挑战

Model drug as pore former for controlled release of water-soluble metoprolol succinate from ethylcellulose-coated pellets without lag phase: opportunities and challenges.

作者信息

Wang Yuli, Dai Jingjing, Chang Xinyi, Yang Meiyan, Shen Ruifang, Shan Li, Qian Yong, Gao Chunsheng

机构信息

Department of Pharmaceutics, Beijing Institute of Pharmacology and Toxicology, No. 27, Taiping Road, Haidian District, Beijing, 100850, People's Republic of China.

出版信息

AAPS PharmSciTech. 2015 Feb;16(1):35-44. doi: 10.1208/s12249-014-0197-5. Epub 2014 Aug 28.

Abstract

The objective of the present study was to evaluate the feasibility of using model drug metoprolol succinate (MS) as a pore former to modify the initial lag phase (i.e., a slow or non-release phase in the first 1-2 h) associated with the drug release from coated pellets. MS-layered cores with high drug-layering efficiency (97% w/w) were first prepared by spraying a highly concentrated drug aqueous solution (60% w/w, 70°C) on non-pareils without using other binders. The presence of MS in ethylcellulose (EC) coating solution significantly improved the coating process by reducing pellets sticking, which often occurs during organic coating. There may be a maximum physical compatibility of MS with EC, and the physical state of the drug in the functional coating layer of EC/MS (80:20) was simultaneously crystalline and non-crystalline (amorphous or solid molecule solution). The lag phase associated with hydroxypropylcellulose (HPC) as a pore former was not observed when MS was used as a pore former. The drug release from EC/MS-coated pellets was pH independent, inversely proportional to the coating levels, and directly related to the pore former levels. The functional coating layer with MS as a pore former was not completely stabilized without curing. Curing at 60°C for 1 day could substantially improve the stability of EC/MS-coated pellets. The physical state of the drug in the free film of EC/MS (85:15) changed partially from amorphous to crystal when cured at 60°C for 1 day, which should be attributed to the incompatibility of the drug with EC.

摘要

本研究的目的是评估使用模型药物琥珀酸美托洛尔(MS)作为成孔剂来改善与包衣微丸药物释放相关的初始延迟期(即最初1-2小时的缓慢或无释放阶段)的可行性。首先通过在不使用其他粘合剂的情况下,将高浓度药物水溶液(60%w/w,70°C)喷洒在空白丸芯上,制备出具有高药物层铺效率(97%w/w)的MS层芯。乙基纤维素(EC)包衣溶液中MS的存在通过减少包衣过程中经常出现的微丸粘连现象,显著改善了包衣工艺。MS与EC之间可能存在最大物理相容性,并且在EC/MS(80:20)功能包衣层中药物的物理状态同时为结晶态和非结晶态(无定形或固体分子溶液)。当使用MS作为成孔剂时,未观察到与作为成孔剂的羟丙基纤维素(HPC)相关的延迟期。从EC/MS包衣微丸释放的药物与pH无关,与包衣水平成反比,与成孔剂水平直接相关。以MS作为成孔剂的功能包衣层未经固化则不完全稳定。在60°C下固化1天可显著提高EC/MS包衣微丸的稳定性。当在60°C下固化1天时,EC/MS(85:15)自由膜中药物的物理状态部分从无定形变为结晶态,这应归因于药物与EC的不相容性。

相似文献

5
Polymer leaching from film coating: effects on the coating transport properties.
Int J Pharm. 2011 Jun 15;411(1-2):43-8. doi: 10.1016/j.ijpharm.2011.03.022. Epub 2011 Mar 21.
6
Osmotic pumping release from ethyl-hydroxypropyl-cellulose-coated pellets: a new mechanistic model.
J Control Release. 2010 Feb 25;142(1):53-60. doi: 10.1016/j.jconrel.2009.10.009. Epub 2009 Oct 28.
7
A Novel Approach for Dry Powder Coating of Pellets with Ethylcellulose. Part II: Evaluation of Caffeine Release.
AAPS PharmSciTech. 2018 Apr;19(3):1426-1436. doi: 10.1208/s12249-018-0964-9. Epub 2018 Feb 13.
8
Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose.
Eur J Pharm Sci. 2009 Jun 28;37(3-4):207-16. doi: 10.1016/j.ejps.2009.02.006. Epub 2009 Feb 21.
9
Curing mechanism of flexible aqueous polymeric coatings.
Eur J Pharm Biopharm. 2017 Jun;115:186-196. doi: 10.1016/j.ejpb.2017.02.012. Epub 2017 Feb 27.
10
The effects of the treatment conditions on the dissolution profile of ethylcellulose coated pellets.
Eur J Pharm Sci. 2019 Apr 30;132:86-95. doi: 10.1016/j.ejps.2019.02.034. Epub 2019 Feb 28.

本文引用的文献

3
Effects of molecular weight on permeability and microstructure of mixed ethyl-hydroxypropyl-cellulose films.
Eur J Pharm Sci. 2013 Jan 23;48(1-2):240-8. doi: 10.1016/j.ejps.2012.11.003. Epub 2012 Nov 16.
4
Effect of the manufacturing conditions on the structure and permeability of polymer films intended for coating undergoing phase separation.
Eur J Pharm Biopharm. 2013 Feb;83(2):301-6. doi: 10.1016/j.ejpb.2012.09.020. Epub 2012 Oct 12.
6
Polymer leaching from film coating: effects on the coating transport properties.
Int J Pharm. 2011 Jun 15;411(1-2):43-8. doi: 10.1016/j.ijpharm.2011.03.022. Epub 2011 Mar 21.
7
Mechanistic modelling of drug release from polymer-coated and swelling and dissolving polymer matrix systems.
Int J Pharm. 2011 Oct 10;418(1):54-77. doi: 10.1016/j.ijpharm.2011.01.021. Epub 2011 Jan 21.
8
In line NIR quantification of film thickness on pharmaceutical pellets during a fluid bed coating process.
Int J Pharm. 2011 Jan 17;403(1-2):66-72. doi: 10.1016/j.ijpharm.2010.10.022. Epub 2010 Oct 28.
9
Design and evaluation of microporous membrane coated matrix tablets for a highly water soluble drug.
Chem Pharm Bull (Tokyo). 2010 Jul;58(7):995-1000. doi: 10.1248/cpb.58.995.
10
Development and optimization of micro/nanoporous osmotic pump tablets.
AAPS PharmSciTech. 2010 Jun;11(2):924-35. doi: 10.1208/s12249-010-9446-4. Epub 2010 May 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验